Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chufang Li

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Antiviral Research|March 24, 2020
Evaluation of the immune response of a H7N9 candidate vaccine virus derived from the fifth wave A/Guangdong/17SF003/2016Ji Dong, Peihai Chen, Yang Wang, et al.
Human Vaccines & Immunotherapeutics|June 16, 2015
Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccineYiling Zhang, Liqiang Feng, Liang Li, et al.
Journal of Virology|October 16, 2015
Proton Channel Activity of Influenza A Virus Matrix Protein 2 Contributes to Autophagy ArrestYizhong Ren, Chufang Li, Liqiang Feng, et al.
Journal of Molecular Biology|July 1, 2009
Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbetaXiaorong Li, Xuan Liu, Guangfei Wang, et al.
Vaccines|February 28, 2023
Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated VaccineJi Dong, Zhenyuan Dong, Pei Feng, et al.
European Journal of Medicinal Chemistry|November 26, 2010
The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetesJifeng Deng, Li Peng, Guicheng Zhang, et al.
Emerging Microbes & Infections|June 8, 2017
Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern ChinaXuehua Zheng, Xia Rong, Ying Feng, et al.
Antiviral Research|April 22, 2014
Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primatesWeiqi Pan, Ling Han, Zhenyuan Dong, et al.
Pharmacological Research|May 4, 2020
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathwayQinhai Ma, Weiqi Pan, Runfeng Li, et al.
Microbiology Spectrum|December 8, 2022
Influenza Virus Infection Increases Host Susceptibility To Secondary Infection with Pseudomonas aeruginosa, and This Is Attributed To Neutrophil Dysfunction through Reduced Myeloperoxidase ActivityFeilong Jie, Xiaofeng Wu, Fan Zhang, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Antiviral Research|March 24, 2020
Evaluation of the immune response of a H7N9 candidate vaccine virus derived from the fifth wave A/Guangdong/17SF003/2016Ji Dong, Peihai Chen, Yang Wang, et al.
Human Vaccines & Immunotherapeutics|June 16, 2015
Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccineYiling Zhang, Liqiang Feng, Liang Li, et al.
Journal of Virology|October 16, 2015
Proton Channel Activity of Influenza A Virus Matrix Protein 2 Contributes to Autophagy ArrestYizhong Ren, Chufang Li, Liqiang Feng, et al.
Journal of Molecular Biology|July 1, 2009
Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbetaXiaorong Li, Xuan Liu, Guangfei Wang, et al.
Vaccines|February 28, 2023
Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated VaccineJi Dong, Zhenyuan Dong, Pei Feng, et al.
European Journal of Medicinal Chemistry|November 26, 2010
The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetesJifeng Deng, Li Peng, Guicheng Zhang, et al.
Emerging Microbes & Infections|June 8, 2017
Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern ChinaXuehua Zheng, Xia Rong, Ying Feng, et al.
Antiviral Research|April 22, 2014
Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primatesWeiqi Pan, Ling Han, Zhenyuan Dong, et al.
Pharmacological Research|May 4, 2020
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathwayQinhai Ma, Weiqi Pan, Runfeng Li, et al.
Microbiology Spectrum|December 8, 2022
Influenza Virus Infection Increases Host Susceptibility To Secondary Infection with Pseudomonas aeruginosa, and This Is Attributed To Neutrophil Dysfunction through Reduced Myeloperoxidase ActivityFeilong Jie, Xiaofeng Wu, Fan Zhang, et al.
Pageof 5